纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg
- 种属
- Human
- 表达系统
- HEK293
蛋白结构
CD44
纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg
蛋白结构
纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg
蛋白结构
纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg
蛋白结构
| 分子名 | 目录号 | 种属 | 表达宿主 | 产品描述 | 蛋白结构 |
|---|---|---|---|---|---|
| CD44 | CD44-AB001 | Human | HEK293 | Anti-CD44 Antibody (Bivatuzumab Biosimilar) 纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg | CD44 |
| CD20 | CD20-AB002 | Human | HEK293 | Anti-CD20 Antibody (Rituximab Biosimilar) 纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg | CD20 |
| CD20 | CD20-AB001 | Human | HEK293 | Anti-CD20 Antibody (Obinutuzumab Biosimilar) 纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg | CD20 |